Back to Search Start Over

Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency

Authors :
Remy S. Petersen, MD
Lauré M. Fijen, MD, PhD
Laurens E. Franssen, MD, PhD
Josephine M.I. Vos, MD, PhD
Danny M. Cohn, MD, PhD
Source :
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 4, Pp 100322- (2024)
Publication Year :
2024
Publisher :
Elsevier, 2024.

Abstract

Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.

Details

Language :
English
ISSN :
27728293
Volume :
3
Issue :
4
Database :
Directory of Open Access Journals
Journal :
Journal of Allergy and Clinical Immunology: Global
Publication Type :
Academic Journal
Accession number :
edsdoj.6c20e97b8c52416c88335adfdabeabe4
Document Type :
article
Full Text :
https://doi.org/10.1016/j.jacig.2024.100322